O'Neil Global Advisors, Inc. Neurocrine Biosciences Inc Transaction History

O'Neil Global Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$130.4 - $143.74 $35,860 - $39,528	275 Added 17.92%	1,810 $250,000
Q4 2023 Feb 09, 2024	SELL	$106.07 - $132.76 $70,324 - $88,019	-663 Reduced 30.16%	1,535 $202,000
Q3 2023 Nov 13, 2023	BUY	$94.02 - $117.1 $206,655 - $257,385	2,198 New	2,198 $247,000
Q4 2022 Feb 14, 2023	SELL	$106.72 - $127.06 $64,138 - $76,363	-601 Reduced 15.49%	3,280 $392,000
Q3 2022 Nov 15, 2022	BUY	$92.03 - $107.81 $357,168 - $418,410	3,881 New	3,881 $412,000

641

95.2M

661K

227K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $10.7B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of O'Neil Global Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on O'Neil Global Advisors, Inc. with notifications on news.